[1] Afrooz H, Ahmadi F, Fallahzadeh F, et al. Design and characterization of paclitaxelverapamil coencapsulated PLGA nanoparticles: potential system for overcoming Pglycoprotein mediated MDR[J]. Journal of Drug Delivery Science and Technology, 2017, 41: 174-181.
[2] Cho K J, Wang X, Nie S M, et al. Therapeutic nanoparticles for drug delivery in cancer[J]. Clinical Cancer Research, 2008, 14(5): 1310-1316.
[3] Kaiser C R, Flenniken M L, Gillitzer E, et al. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo[J]. International Journal of Nanomedicine, 2007, 2(4): 715-733.
[4] Le D H T, Lee K L, Shukla S, et al. Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy[J]. Nanoscale, 2017, 9(6): 2348-2357.
[5] Czapar A E, Zheng Y R, Riddell I A, et al. Tobacco mosaic virus delivery of phenanthriplatin for cancer therapy[J]. Acs Nano, 2016, 10(4): 4119-4126.
[6] 李凯, 张金玲, 王倩, 等. 病毒纳米颗粒在医学领域的潜在应用[J]. 生物医学工程杂志, 2014, 31(3): 718-722.
[7] Alemzadeh E, Dehshahri A, Izadpanah K, et al. Plant virus nanoparticles: novel and robust nanocarriers for drug delivery and imaging[J]. Colloids and Surfaces BBiointerfaces, 2018, 167: 20-27.
[8] Allen T M, Cullis P R. Drug delivery systems: entering the mainstream[J]. Science, 2004, 303(5665): 1818-1822.
[9] Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness[J]. The American Journal of Pathology, 2000, 156(4): 1363-1380.
[10] Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review[J]. Journal of Controlled Release, 2000, 65(1/2): 271-284.
[1]雷容,徐江晖,周文翠,等.多孔丝素颗粒的可控制备及药物负载研究[J].浙江理工大学学报,2018,39-40(自科1):37.
LEI Rong,XU Jianghui,ZHOU Wencui,et al.Sizecontrolled preparation of porous silk fibroin particle used as drug carrier[J].Journal of Zhejiang Sci-Tech University,2018,39-40(自科一):37.